pharma · Diphtheria · Diabetes Mellitus, Type 2
Sanofi Pasteur MSD
Sanofi Pasteur
Sanofi Pasteur is a pharma organization headquartered in LYON, FR. Primary therapeutic focus areas include Diphtheria, Diabetes Mellitus, Type 2, Japanese Encephalitis, Rabies, Hemophilia A. NovaPharmaNews links 83 clini
France, LYON HQ
363 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- France, LYON
- Employees
- 363
- Programs
- 83
- Drugs
- 66
- Patents
- 0
risedronate sodium
Approved · small molecule · Osteoporosis, Postmenopausal
risedronate sodium for Osteoporosis, Postmenopausal is a Approved program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Internal code HMR4003B_4034
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Sanofi Pasteur
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Osteoporosis, Postmenopausal
- Status
- completed
- Trials
- 1